Hsbc Holdings PLC decreased its position in shares of Colgate-Palmolive Company (NYSE:CL – Free Report) by 0.5% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,750,495 shares of the company’s stock after selling 9,348 shares during the period. Hsbc Holdings PLC owned 0.22% of Colgate-Palmolive worth $138,311,000 as of its most recent SEC filing.
A number of other hedge funds have also recently bought and sold shares of CL. HighPoint Advisor Group LLC lifted its stake in shares of Colgate-Palmolive by 0.7% during the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after purchasing an additional 109 shares during the period. Clear Harbor Asset Management LLC grew its position in shares of Colgate-Palmolive by 2.6% in the fourth quarter. Clear Harbor Asset Management LLC now owns 4,503 shares of the company’s stock valued at $356,000 after purchasing an additional 113 shares during the period. Moneta Group Investment Advisors LLC increased its stake in Colgate-Palmolive by 0.7% in the fourth quarter. Moneta Group Investment Advisors LLC now owns 15,506 shares of the company’s stock valued at $1,225,000 after purchasing an additional 114 shares during the last quarter. Sunpointe LLC increased its stake in Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after purchasing an additional 117 shares during the last quarter. Finally, TD Capital Management LLC lifted its position in Colgate-Palmolive by 61.4% during the fourth quarter. TD Capital Management LLC now owns 326 shares of the company’s stock worth $26,000 after buying an additional 124 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.
Colgate-Palmolive Price Performance
CL stock opened at $89.74 on Friday. The stock has a 50-day moving average price of $87.40 and a two-hundred day moving average price of $86.60. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. The company has a market cap of $71.81 billion, a PE ratio of 34.92, a price-to-earnings-growth ratio of 4.72 and a beta of 0.33.
Colgate-Palmolive Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Investors of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a yield of 2.4%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 82.49%.
Wall Street Analysts Forecast Growth
A number of analysts have issued reports on CL shares. Rothschild & Co Redburn set a $100.00 price target on Colgate-Palmolive and gave the stock a “buy” rating in a research note on Tuesday, April 21st. Barclays increased their price objective on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a report on Tuesday, May 5th. Royal Bank Of Canada reissued an “outperform” rating and issued a $102.00 target price on shares of Colgate-Palmolive in a research report on Monday, May 4th. Weiss Ratings upgraded shares of Colgate-Palmolive from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Finally, Wells Fargo & Company dropped their price target on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 8th. Twelve analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $95.88.
View Our Latest Stock Report on Colgate-Palmolive
About Colgate-Palmolive
Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.
The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.
Featured Stories
- Five stocks we like better than Colgate-Palmolive
- 3 Retail Winners Using Cash Flow to Stay Ahead
- 3 Tech ETFs That Could Bounce Back After the AI Selloff
- 3 Penny Stocks Under $5 Backed by Real Revenue Growth
- 3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive Company (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.
